Corticosteroid plus β(2)-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis

BACKGROUND: Current guidelines recommend a single inhaler maintenance and reliever therapy (SMART) regimen for moderate to severe asthma. However, evidence for the inhaled corticosteroid plus fast-onset-acting β(2)-agonist (ICS/FABA) as reliever therapy in management of intermittent and mild asthma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Gang, Zhang, Xin, Zhang, Hong Ping, Wang, Lei, Kang, De Ying, Barnes, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718039/
https://www.ncbi.nlm.nih.gov/pubmed/29207999
http://dx.doi.org/10.1186/s12931-017-0687-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718039/
https://www.ncbi.nlm.nih.gov/pubmed/29207999
http://dx.doi.org/10.1186/s12931-017-0687-6

Ejemplares similares